Is there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis?

Osteoarthritis and Cartilage

Volumn 11, Issue 2, 2003, Pages 87-91

  Reginster, J Y ^a,b   Kvasz, A ^b   Bruyere, O ^a,b   Henrotin, Y ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Estrogens; Hormone replacement therapy; Osteoarthritis; Treatment prevention

Indexed keywords

BOLDENONE; COLLAGEN TYPE 2; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PROTEOGLYCAN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 2; TAMOXIFEN; TESTOSTERONE;

CARDIOVASCULAR DISEASE; CARTILAGE; CHRONIC DISEASE; DISEASE ACTIVITY; DISEASE COURSE; EDITORIAL; HEALTH HAZARD; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HORMONE URINE LEVEL; HUMAN; INCIDENCE; NONHUMAN; OSTEOARTHRITIS; OUTCOMES RESEARCH; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

EID: 0037320034     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2002.0872     Document Type: Editorial

References (47)

1. Lunenfeld B. Aging for men. In: Archer JS, Bentley RC, Brandi ML, Cano A, Compston J, Di Carlo C, et al, Eds. The Management of the Menopause. The Millennium Review 2000. London: The Parthenon Publishing Group 2000:3-10.
2. Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620-7.
3. Grodstein F, Stampfer MJ, Manson JE. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61.
4. Sherwin BA. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20-6.
5. Calaf i Alsina J. Benefits of hormone replacement therapy - overview and update. Int J Fertil 1997;42:329-46.
6. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
7. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA 2002;288:366-8.
8. Ushiyama T, Inoue K, Nishioka J. Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 1995;22:421-6.
9. Rosner IA, Manni A, Malemud CJ, Boja B, Moskowitz RM. Estradiol receptors in articular chondrocytes,. Biochem Biophys Res Commun 1982;106:1378-82.
10. Dayani N, Corvol MT, Robel P, Eychenne B, Moncharmont B, Tsagris L, et al. Estrogen receptors in cultured rabbit articular chondrocytes: influence of age. J Steroid Biochem 1988;31:351-6.
11. Blanchard O, Tsagris L, Rappaport R, Duval-Beaupere G, Corvol M. Age-dependent responsiveness of rabbit and human cartilage cells to sex steroids in vitro. J Steroid Biochem Molec Biol 1991;40:711-16.
12. Milam SB, Aufdemorte TB, Sheridan PJ, Triplett RG, van Sickels JF, Holt GR. Sexual dimorphism in the distribution of estrogen receptors in the temporo-mandibular joint complex of the baboon. Oral Surg Oral Med Pathol 1987;64:527-32.
13. Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF. Functional estrogen receptors in adult articular cartilage. Estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 2000;43:2081-90.
14. Fernihough JK, Richmond RS, Carlson CS, Cherpes T, Holly JM, Loeser RF. Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum 1999;42:2103-11.
15. Franchimont P, Bassleer C. Effects of hormones and local growth factors on articular chondrocyte metabolism. J Rheumatol 1991;18:68-70.
16. Rosner IA, Goldberg VM, Getzy L, Moskowitz RW. Effects of estrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum 1979;22:52-8.
17. Makintosh D, Mason RM. Pharmacological actions of 17β-oestradiol on articular cartilage chondrocytes and chondrosarcoma chondrocytes in the absence of oestrogen receptors. Biochim Biophys Acta 1988; 964:295-302.
18. Tsai CL, Liu TK, Chen TJ. Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees. Life Sci 1992;183:1287-91.
19. Tsai CL, Liu TK. Up-regulation of estrogen receptors in rabbit osteoarthritic cartilage. Life Sci 1992;50:1727-35.
20. Tsai CL, Liu TK. Estradiol-induced knee osteoarthrosis in ovariectomized rabbits. Clinical Orthop Rel Res 1993;291:295-302.
21. Tsai CL, Liu TK. Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen. Life Sci 1992;50:1943-51.
22. Turner AS, Athanasiou KA, Zhu CF, Alvis MR, Bryant HU. Biochemical effects of estrogen on articular cartilage in ovariectomized sheep. Osteoarthritis Cart 1997;5:63-9.
23. Cecil RL, Archer BH. Classification and treatment of chronic arthritis. JAMA 1926;87:741-6.
24. Spector TD, Campion GD. Generalised osteoarthritis: a hormonally mediated disease. Ann Rheum Dis 1989;48:523-7.
25. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: The disease and its risk factors. Ann Intern Med 2000;133:635-46.
26. Spector TD, Perry LA, Jubb RW. Endogenous sex steroids levels in women with generalised osteoarthritis. Clin Rheum 1991;10:316-19.
27. Cauley JA, Kwoh KC, Egeland G, Nevitt MC, Cooperstein L, Rohay J, et al. Serum sex hormones and severity of osteoarthritis of the hand. J Rheumatol 1993;20:1170-5.
28. Samanta A, Jones A, Regan M, Wilson S, Doherty M. Is osteoarthritis in women affected by hormonal changes or smoking? Brit J Rheumatol 1993;32:366-70.
29. Dequeker J. The relationship between osteoporosis and osteoarthritis. Clin Rheum Dis 1985;11:271-96.
30. Foss MVL, Byers PD. Bone density, osteoarthrosis of the hip and fracture of the upper end of the femur. Ann Rheum Dis 1972;31:259-64.
31. Hart DJ, Mootoosamy I, Doyle DV, Spector TD. The relationship between osteoarthritis and osteoporosis in the general population: the Chingford Study. Ann Rheum Dis 1994;53:158-62.
32. Lethbridge-Cejku M, Tobin JD, Scott WW, Reichle R, Roy TA, Plato CC, et al. Axial and hip bone mineral density and radiographic changes of osteoarthritis of the knee: Data from the Baltimore longitudinal study of aging. J Rheumatol 1996;23:1943-7.
33. Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT. Bone mineral density and knee osteoarthritis in elderly men and women: the Framingham Study. Arthritis Rheum 1993;36:1671-80.
34. Antoniades L, MacGregor AJ, Matson M, Spector TD. A cotwin control study of the relationship between hip osteoarthritis and bone mineral density. Arthritis Rheum 2000;43:1450-5.
35. Ushiyama T, Ueyama H, Inoue K, Nishioka J, Ohkubo I, Hukuda S. Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol 1998; 25:134-7.
36. Reginster JY, Bruyere O, Audran M, Avouac B, Body JJ, Bouvenot G, et al. (GREES). Do estrogens effectively prevent osteoporosis-related fractures? Calcif Tissue Int 2000;67:191-4.
37. Erb A, Brenner H, Günther KP, Stürmer T. Hormone replacement therapy and patterns of osteoarthritis: baseline data from the Ulm Osteoarthritis Study. Ann Rheum Dis 2000;59:105-9.
38. Spector TD, Nandra D, Hart DJ, Voyle DV. Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford Study. Ann Rheum Dis 1997;56:432-4.
39. Maheu E, Dreiser RL, Guillou GB, Dewailly J. Hand osteoarthritis patients characteristics according to the existence of a hormone replacement therapy. Osteoarthritis Cart 2000;8:33-7.
40. Nevitt MC, Cumming SR, Lane NE, Hochberg MC, Scott JC, Pressman AR, et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Arch Intern Med 1996;156:2073-80.
41. Dennison EM, Arden NK, Kellingray S, Croft P, Coggon D, Cooper C. Hormone replacement therapy, other reproductive variables and symptomatic hip osteoarthritis in elderly white women: a case-control study. Brit J Rheumatol 1998;37:1198-202.
42. Nevitt MC, Felson DT, Williams EN, Grady D. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women. Arthritis Rheum 2001;44:811-18.
43. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 2001;60:332-6.
44. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women. Arthritis Rheum 1999;42:17-24.
45. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women. The Framigham Osteoarthritis Study. Arthritis Rheum 1990;33:525-32.
46. Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R, Wilson PWF, et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis. Arthritis Rheum 1998;41:1867-73.
47. Sandmark H, Hogstedt C, Lewold S, Vingârd E. Osteoarthrosis of the knee in men and women in association with overweight, smoking, and hormone therapy. Ann Rheum Dis 1999;58:151-5.